LifePoint Health, Inc.
LPNT
LPNT was delisted on the 15th of November, 2018.
221 hedge funds and large institutions have $2.35B invested in LifePoint Health, Inc. in 2013 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 86 reducing their positions, and 37 closing their positions.
16% more capital invested
Capital invested by funds: $2.02B → $2.35B (+$328M)
3% less funds holding
Funds holding: 229 → 221 (-8)
16% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 86
19% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 37
33% less call options, than puts
Call options by funds: $464K | Put options by funds: $697K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
+$48.2M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$31.2M |
| 3 |
CRAM
Claren Road Asset Management
New York
|
+$19.6M |
| 4 |
CM
Corvex Management
New York
|
+$18.5M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$13.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$42.7M |
| 2 |
Bank of New York Mellon
New York
|
-$24.1M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
-$15.7M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$11.4M |
| 5 |
D.E. Shaw & Co
New York
|
-$9.85M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
QT
251
Quantbot Technologies
New York
| – | -$191K | -4,100 | Closed |
|
|
PA
252
Perceptive Advisors
New York
| – | -$140K | -2,995 | Closed |
|
253
Walleye Trading
New York
| – | -$86K | -1,851 | Closed |
|
254
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$35K | -749 | Closed |
|
255
Parallax Volatility Advisers
San Francisco,
California
| – | -$21K | -449 | Closed |
|
|
OC
256
Oakworth Capital
Birmingham,
Alabama
| – | +$402 | +8 | New |
|
LPNT Hedge Fund Activity: Q4 2013 in Review
221 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in LifePoint Health, Inc. (LPNT) for Q4 2013, worth a combined $2.35B — up 16% from $2.02B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of LPNT and 30 opened new positions — a net loss of 7 holders — while 86 trimmed existing stakes and 72 added.
The largest buyer was Glenview Capital Management, adding an estimated $48.2M. The largest seller was Wellington Management Group, cutting an estimated $42.7M.
- 221 institutional investors held LifePoint Health, Inc. (LPNT) as of Q4 2013, down from 229 in Q3 2013.
- Funds reported $2.35B of LifePoint Health, Inc. stock for Q4 2013, up 16% quarter-over-quarter.
- 30 funds opened new LifePoint Health, Inc. positions in Q4 2013 and 37 closed out, a net change of -7 holders.
- The largest LifePoint Health, Inc. buyer in Q4 2013 was Glenview Capital Management, an estimated $48.2M added.
- The largest LifePoint Health, Inc. seller in Q4 2013 was Wellington Management Group, an estimated $42.7M sold.
Based on aggregated 13F filings for Q4 2013.